Back
CASI Pharmaceuticals Quote, Financials, Valuation and Earnings
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
27
CASI
CASI Pharmaceuticals
Last Price:
3.64
Seasonality Move:
4.2%
7 Day Trial
ALL ACCESS PASS
$
7
32,481% Growth: Invest in the Smartphone Revolution @ $0.26/Share
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.CASI Pharmaceuticals Price Quote
$3.64
+0.07 (+-7.81%)
(Updated: December 4, 2024 at 4:59 AM ET)
CASI Pharmaceuticals Key Stats
Sell
27
CASI Pharmaceuticals (CASI)
is a Sell
Day range:
$3.57 - $4.05
52-week range:
$2.05 - $8.48
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.25
P/B ratio:
3.99%
Volume:
45.6K
Avg. volume:
38.1K
1-year change:
-36.14%
Market cap:
$55.2M
Revenue:
$33.9M
EPS:
$-2.24
How Much Does CASI Pharmaceuticals Make?
-
How Much Are CASI Pharmaceuticals's Sales Annually?
CASI Revenues are $33.9M -
How Much Profit Does CASI Pharmaceuticals's Make A Year?
CASI net income is -$26.9M
Is CASI Pharmaceuticals Growing As A Company?
-
What Is CASI Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.12% -
What Is CASI Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
CASI Pharmaceuticals Stock Price Performance
-
Did CASI Pharmaceuticals Stock Go Up Last Month?
CASI Pharmaceuticals share price went down by -40.6% last month -
Did CASI's Share Price Rise Over The Last Year?
CASI share price fell by -36.14% over the past 1 year
What Is CASI Pharmaceuticals 52-Week High & Low?
-
What Is CASI Pharmaceuticals’s 52-Week High Share Price?
CASI Pharmaceuticals has traded as high as $8.48 over the past 52 weeks -
What Is CASI Pharmaceuticals’s 52-Week Low Share Price?
CASI Pharmaceuticals has traded as low as $2.05 over the past 52 weeks
CASI Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy CASI Pharmaceuticals?
-
How Much Debt Does CASI Pharmaceuticals Have?
Total long term debt quarterly is $19.1M -
How Much Cash Does CASI Pharmaceuticals Have?
Cash and short term investments quarterly total is $20.8M -
What Is CASI Pharmaceuticals’s Book Value Per Share?
Book value per share is 0.90
Is CASI Pharmaceuticals Cash Flow Positive?
Data Unavailable
CASI Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
CASI return on invested capital is -82.29% -
What Is CASI Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is -47.99% -
What Is CASI Return On Equity?
ROE is a measure of profitability and is -137%
CASI Pharmaceuticals Earnings Date & Stock Price
-
What Is CASI Pharmaceuticals's Stock Price Today?
A single share of CASI can be purchased today for 3.57 -
What Is CASI Pharmaceuticals’s Stock Symbol?
CASI Pharmaceuticals trades on the nasdaq under the ticker symbol: CASI -
When Is CASI Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for CASI Pharmaceuticals is scheduled on March 28, 2025 -
When Is CASI's next ex-dividend date?
CASI Pharmaceuticals's next ex-dividend date is May 1, 2020 -
How To Buy CASI Pharmaceuticals Stock?
You can buy CASI Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
CASI Pharmaceuticals Competitors
-
Who Are CASI Pharmaceuticals's Competitors?
Below is a list of companies who compete with CASI Pharmaceuticals or are related in some way:
CASI Pharmaceuticals Dividend Yield
-
What Is CASI Dividend Yield?
CASI Pharmaceuticals’s dividend yield currently is 0% -
What Is CASI Pharmaceuticals’s Payout Ratio?
CASI Pharmaceuticals’s payout ratio is 0% -
When Did CASI Pharmaceuticals Last Pay A Dividend?
The latest dividend pay date is December 4, 2024 -
What Is CASI Pharmaceuticals’s Dividend Per Share?
CASI Pharmaceuticals pays a dividend of $0.00 per share
CASI Pharmaceuticals Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 0% |
| Revenue: | -11.82% | 70.9% |
Analyst Recommendations
| Buy Recommendations: | 0 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 6.00 |
| Upside from Last Price: | 68.07% |